CoChat

Clinical Trial Generalizability Assessment in the Big Data Era: A Review

Open access
He, Zhe, Tang, Xiang, Yang, Xi, Guo, Yi, George, Thomas J., Charness, Neil, Quan Hem, Kelsa Bartley, Hogan, William, Bian, Jiang · 2020 · Clinical and Translational Science
Cited by 130

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Clinical studies, especially randomized, controlled trials, are essential for generating evidence for clinical practice. However, generalizability is a long‐standing concern when applying trial results to real‐world patients. Generalizability assessment is thus important, nevertheless, not consistently practiced. We performed a systematic review to understand the practice of generalizability assessment. We identified 187 relevant articles and systematically organized these studies in a taxonomy with three dimensions: (i) data availability (i.e., before or after trial (a priori vs. a posteriori generalizability)); (ii) result outputs (i.e., score vs. nonscore); and (iii) populations of interest. We further reported disease areas, underrepresented subgroups, and types of data used to profile target populations. We observed an increasing trend of generalizability assessments, but < 30% of studies reported positive generalizability results. As a priori generalizability can be assessed using only study design information (primarily eligibility criteria), it gives investigators a golden opportunity to adjust the study design before the trial starts. Nevertheless, < 40% of the studies in our review assessed a priori generalizability. With the wide adoption of electronic health records systems, rich real‐world patient databases are increasingly available for generalizability assessment; however, informatics tools are lacking to support the adoption of generalizability assessment practice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cts.12764

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 58

  1. 10.1136/bmj.e1004 · DOI
  2. 10.1056/NEJMp1615879 · DOI · Paper page
  3. 10.1097/AOG.0b013e3182a9ca67 · DOI · Paper page
  4. 10.1016/j.jpsychores.2013.12.007 · DOI
  5. 10.1377/hlthaff.2014.0122 · DOI
  6. 10.1136/bmj.333.7563.346 · DOI · Paper page
  7. 10.4088/JCP.12m07935 · DOI · Paper page
  8. 10.1177/1740774515571917 · DOI
  9. 10.1186/1745-6215-13-237 · DOI
  10. 10.1002/mpr.1609 · DOI
  11. 10.1016/j.jad.2017.01.008 · DOI
  12. 10.1136/bmj.b2535 · DOI · Paper page
  13. 10.11613/BM.2012.031 · DOI · Paper page
  14. 10.1093/aje/kwx164 · DOI · Paper page
  15. 10.1093/aje/kwq084 · DOI · Paper page
  16. 10.1093/aje/kwq084 · DOI · Paper page
  17. 10.1177/0193841X16660663 · DOI
  18. 10.1016/j.tips.2015.08.007 · DOI
  19. 10.4338/ACI-2013-12-RA-0105 · DOI
  20. 10.1016/j.jbi.2016.01.007 · DOI
  21. 10.1016/j.jbi.2016.09.003 · DOI
  22. 10.1111/nyas.13195 · DOI
  23. 10.1016/j.jacc.2015.10.037 · DOI · Paper page
  24. 10.1093/cid/civ1222 · DOI
  25. 10.1111/ajad.12714 · DOI
  26. 10.1046/j.1468-1293.2000.00019.x · DOI
  27. 10.1016/j.ijmedinf.2016.12.008 · DOI
  28. 10.1111/j.1467-985X.2010.00673.x · DOI · Paper page
  29. 10.1111/add.13327 · DOI
  30. 10.1007/s12032-018-1167-7 · DOI
  31. 10.1016/j.cardfail.2017.04.006 · DOI
  32. 10.1007/s00586-016-4850-4 · DOI
  33. Wittbrodt E.T., 2018, Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials enrollment criteria to the US type 2 diabetes population, Am. J. Manag. Care, 24, S146
  34. 10.1016/j.jclinepi.2017.10.016 · DOI
  35. 10.1186/1471-2482-12-2 · DOI
  36. 10.1016/S0165-5876(01)00504-3 · DOI
  37. 10.1186/1745-6215-15-310 · DOI
  38. 10.3390/jcm7080206 · DOI
  39. 10.1111/bjd.17849 · DOI
  40. 10.1016/S0304-3959(99)00074-3 · DOI · Paper page
  41. 10.1007/s00381-016-3328-3 · doi:10.1007/s00381-016-3328-3
  42. 10.1093/aje/kwx287 · DOI
  43. 10.1001/archinte.167.1.68 · DOI · Paper page
  44. 10.1016/j.eururo.2018.10.054 · doi:10.1016/j.eururo.2018.10.054
  45. Botsis T., 2010, Secondary use of EHR: data quality issues and informatics opportunities, Summit Transl. Bioinform., 2010, 1
  46. 10.1016/j.jbi.2014.01.009 · DOI · Paper page
  47. 10.1001/jama.297.11.1233 · DOI · Paper page
  48. 10.1200/JCO.2007.15.3726 · DOI · Paper page
  49. 10.2217/cer.15.27 · DOI
  50. 10.1001/jama.2019.17016 · doi:10.1001/jama.2019.17016
  51. 10.1002/pds.4718 · DOI
  52. Zhang H., 2018, Computable eligibility criteria through ontology‐driven data access: a case study of hepatitis C virus trials, AMIA Ann. Symp. Proc., 2018, 1601
  53. 10.1038/nrd.2017.25 · DOI
  54. Lane K., 2018, African American screening and enrollment in (clot lysis: evaluating accelerated resolution of intraventricular hemorrhage III) CLEAR III, Clin. Res. (Alex.), 32
  55. 10.1016/j.drugalcdep.2017.02.024 · DOI
  56. 10.1177/2047487318815967 · doi:10.1177/2047487318815967
  57. 10.18553/jmcp.2017.16367 · DOI
  58. 10.1370/afm.516 · DOI · Paper page

Cited by

See all 130

Metadata

Authors
He, Z., Tang, X., Yang, X., Guo, Y., George, T. J., Charness, N., Quan Hem, K. B., Hogan, W., & Bian, J.
Venue
Clinical and Translational Science
Publisher
Wiley
Published
2020-04-10
Volume
13
Issue
4
Pages
675-684
ISSN
  • 1752-8054 (ISSN-L)
  • 1752-8062
OpenAlex
W3006162251
Cited by
130
References
8
FWCI
8.81
Type
journal article
Language
en
Open access
gold
Funders
  • National Institute on Aging
  • National Institutes of Health (R21AG061431;, UL1TR001427)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Trial Generalizability Assessment in the Big Data Era: A Review. https://app.cochat.ai/papers/10.1111/cts.12764
The paper
He, Z., Tang, X., Yang, X., Guo, Y., George, T. J., Charness, N., Quan Hem, K. B., Hogan, W., & Bian, J. (2020). Clinical Trial Generalizability Assessment in the Big Data Era: A Review. Clinical and Translational Science. https://doi.org/10.1111/cts.12764

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.